Mackay Shields LLC’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-19,375
Closed -$887K 1525
2020
Q3
$887K Buy
19,375
+500
+3% +$22.9K 0.01% 1055
2020
Q2
$947K Sell
18,875
-4,400
-19% -$221K 0.01% 1039
2020
Q1
$1.2M Buy
23,275
+5,300
+29% +$273K 0.01% 885
2019
Q4
$1.11M Sell
17,975
-2,800
-13% -$173K 0.01% 1046
2019
Q3
$1.25M Buy
20,775
+2,800
+16% +$168K 0.01% 1062
2019
Q2
$1.52M Buy
17,975
+11,183
+165% +$944K 0.01% 1006
2019
Q1
$649K Hold
6,792
﹤0.01% 1118
2018
Q4
$481K Buy
6,792
+292
+4% +$20.7K ﹤0.01% 1152
2018
Q3
$555K Buy
+6,500
New +$555K ﹤0.01% 988